Why does hormonal contraception and menopausal hormonal treatment have such a small effect on breast cancer risk?

被引:0
|
作者
Eden, John A. [1 ]
机构
[1] Univ NSW, Royal Hosp Women, Sydney, NSW, Australia
关键词
breast cancer; causality; contraception; menopausal hormone therapy; risk factor; PROGESTERONE PROGESTERONE; STEM-CELLS; ESTROGEN; THERAPY;
D O I
10.1111/ajo.13825
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Oestrogen is considered by many to be a major cause of breast cancer, and yet hormonal contraception and menopausal hormonal therapy have a paradoxically small effect on breast cancer risk. Also, in the oestrogen-only arm of the Women's Health Initiative, subjects given oestrogen had a reduced risk of breast cancer compared to controls. Initiation of breast cancer likely begins early in life, in the long-lived ER-PR- breast stem cell. The main mitogen of ER+PR+ breast cancers is oestrogen derived from local breast fat and the tumour itself, rather than circulating oestrogens. Progesterone is relatively breast neutral, but progestins in the laboratory have been shown to expand malignant breast stem cell number.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Hormonal Contraception (HC) - a Cancer Risk
    Neulen, J.
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2006, 4 (02): : 89 - 91
  • [22] Breast cancer risk with postmenopausal hormonal treatment
    Collins, JA
    Blake, JM
    Crosignani, PG
    HUMAN REPRODUCTION UPDATE, 2005, 11 (06) : 545 - 560
  • [23] The Relationship between Hormonal Contraception and Breast Cancer
    Mohamed, Adel Mahjoub Musa
    Alshammari, Fatimah Khalifah Ayed
    Alotayfi, Razan Fahad Saleh
    Alenazi, Khawlah Hameed Mamlooh
    Alruwaili, Amjad Mofareh S.
    ARCHIVES OF PHARMACY PRACTICE, 2020, 11 (04) : 124 - 129
  • [24] Hormonal Contraception and Breast Cancer: Keeping Perspective
    Reid, Robert L.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2007, 29 (03) : 207 - 209
  • [25] Breast cancer risk of hormonal contraception: Counselling considering new evidence
    Del Pup, Lino
    Codacci-Pisanelli, Giovanni
    Peccatori, Fedro
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 137 : 123 - 130
  • [26] Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment
    Glaus, A
    Boehme, C
    Thürlimann, B
    Ruhstaller, T
    Schmitz, SFH
    Morant, R
    Senn, HJ
    von Moos, R
    ANNALS OF ONCOLOGY, 2006, 17 (05) : 801 - 806
  • [27] Duration of Hormonal Contraception and Risk of Cervical Cancer
    Kusmiyati, Yuni
    Prasistyami, Annisaputri
    Wahyuningsih, Heni Puji
    Widyasih, Hesty
    Adnani, Qorinah Estiningtyas Sakilah
    KESMAS-NATIONAL PUBLIC HEALTH JOURNAL, 2019, 14 (01): : 9 - 13
  • [28] Non hormonal contraception and the risk of ovarian cancer
    Weiss, NS
    Rossing, MA
    EPIDEMIOLOGY, 2001, 12 (03) : 300 - 300
  • [29] Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk
    Satish, Sanjana
    Moore, Jessica F.
    Littlefield, Jay M.
    Bishop, Ian J.
    Rojas, Kristin E.
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 227 - 235
  • [30] Breast cancer in menopausal women with hormonal replacement therapy
    Rosales, E
    Sordia, L
    Vazquez, J
    Iglesias, JL
    Morales, A
    Castañeda, M
    Vidal, O
    Saldivar, D
    Merino, M
    García, M
    RESEARCH PAPERS IN FERTILITY AND REPRODUCTIVE MEDICINE, 2004, 1271 : 414 - 416